IHS Chemical Week
FINE CHEMICALS/BIOTECH

GSK shareholders approve $20-billion asset deal with Novartis

9:47 AM MST | December 19, 2014 | Natasha Alperowicz

Shareholders of GlaxoSmithKline (GSK) on Thursday approved by an overwhelming majoring a planned deal with Novartis, which sets the two pharma groups to trade more than $20.0 billion of assets. The transaction, which includes GSK buying Novartis's vaccines...


Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com
MORE FINE CHEMICALS/BIOTECH

Bayer to outsource production of major drug to Cardinal Health

Bayer HealthCare and Cardinal Health (Dublin, OH) have signed a 15-year agreement for the contract manufacturing of Bayer’s Xofigo (radium Ra 223 dichloride) drug. As part of the agreement, Cardinal Health will build a 64,000-square foot facility in...

UCB terminates agreement to sell generic drugs unit to private equity groups

UCB, Advent International and Avista Capital Partners said on Tuesday that they have agreed to terminate their agreement, announced on 7 November 2014, for Advent and Avista to acquire UCB’s US specialty generics subsidiary, Kremers Urban...

Abbott completes acquisition of Russian pharma firm

Abbott has announced the completion of the purchase of Veropharm, a leading Russian pharmaceuticals manufacturer. Abbott announced in June that it acquired control of Veropharm for 16.7 billion Russian rubles ($291.1 million) through its purchase of Garden...

EU survey of pesticide residues in food: More than 50% of samples show no detectable residues

The European Food Safety Authority (EFSA; Parma, Italy) has reported the results of the latest Europe-wide monitoring program in its 2012 annual report on pesticide residues in food. The report is based on an analysis of food samples carried out by 27...

Cipla sells its stake in Chinese pharma company

Pharmaceuticals producer Cipla (Mumbai) has announced the sale its stake in Jiangsu Cdymax Pharmaceuticals for $18.5 million as part of a realignment of its global business. Cipla says that its wholly-owned subsidiary Meditab Holdings (Mauritius) has entered...

Pharma/fine chemicals roundup—9 December 2014

Johnson Matthey acquires pharmaceutical ingredients facility in UK Johnson Matthey says that it has completed the acquisition of a pharmaceutical manufacturing facility at Annan, UK. The site, which was originally constructed by Glaxo in 1980, changed hands...

Adama to invest $50 million to expand operations in India

Adama Agricultural Solutions, formerly Makhteshim Agan, said today that it will invest $50 million more in India over the next three to four years in distribution network, R&D and manufacturing. The company has already invested $50 million since it...

Aurobindo completes acquisition of US nutraceuticals firm Natrol

Aurobindo Pharma (Hyderabad, India) said on Friday that it had completed acquiring assets of nutritional supplement maker Natrol and other affiliate entities through a wholly owned US subsidiary. This subsidiary emerged as the highest bidder to acquire Natrol...

Merck to acquire Cubist Pharmaceuticals for $8.40 billion

Merck announced today that it has reached an agreement to acquire Cubist Pharmaceuticals (Lexington, MA) for $102/share in cash, which represents a 35% premium to Cubist’s average stock price for the most recent five trading days. The transaction...

Fine Chemicals/Biotech Archives »











 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa